GPT Healthcare IPO consists of a fresh issue of shares worth INR 40 crores and an offer to sell 2.60 crore existing equity shares. The company seeks funds for loan repayment, prepayment, and general corporate funding purposes.
GPT Healthcare Limited IPO – Important Details
| GPT Healthcare IPO Date | February 22, 2024 to February 26, 2024 |
| GPT Healthcare IPO Listing Date | February 29, 2024 |
| GPT Healthcare IPO Price | INR 177 to 186 per share |
| GPT Healthcare IPO Lot Size | 80 Shares |
| GPT Healthcare IPO Total Issue Size | 525.14 Cr |
| GPT Healthcare IPO Basis of Allotment | February 27, 2024 |
| GPT Healthcare IPO Initiation of Refunds | February 28, 2024 |
| GPT Healthcare IPO Credit of Shares to Demat | February 28, 2024 |
| GPT Healthcare IPO Issue Type | Book Built Issue |
| GPT Healthcare IPO Listing At | BSE, NSE |
GPT Healthcare Ltd IPO – Company Profile
GPT Healthcare, a prominent player in Eastern India’s healthcare sector, boasts a chain of mid-sized full-service hospitals, prioritizing secondary and tertiary care. Leading in beds and hospitals, it emphasizes integrated healthcare services.
They operate four multispecialty hospitals across West Bengal and Tripura, with 561 beds. Offering over 35 specialties, including internal medicine, surgery, and critical care, each hospital provides integrated diagnostics and pharmacies.
They strategically target Eastern India’s under-penetrated healthcare market, present in three cities. This fosters an understanding of regional nuances, patient culture, and medical professionals’ mindset, addressing the need for quality and affordable services.
GPT Healthcare Limited IPO – Fundamental Analysis
GPT Healthcare Ltd’s IPO financials reveal consistent revenue growth, notable profitability, and improved debt management, positioning it as a compelling investment within the healthcare sector with strong operational efficiency and a promising outlook for future growth.
Revenue Growth:
The company has demonstrated consistent revenue growth from ₹2,427.53 million in 2021 to ₹3,610.37 million in 2023. This steady increase suggests a solid demand for its healthcare services and an expanding market presence.
Equity Expansion:
Equity has gradually increased from ₹1,339.01 million in 2021 to ₹1,653.62 million in 2023, reflecting the company’s ability to accumulate assets and possibly retain earnings for future growth.
Profitability:
Profit after tax has grown from ₹210.93 million in 2021 to a peak of ₹416.63 million in 2022 before slightly decreasing to ₹390.08 million in 2023. This indicates effective cost management and operational efficiency, even as expenses have increased with revenue.
Return on Net Worth (RoNW):
The RoNW has seen a significant increase, peaking at 26.54% in 2022 and stabilizing at 23.77% in 2023, showcasing the company’s ability to efficiently generate profits from its equity base.
Diluted EPS:
The Diluted EPS has increased from ₹2.64 in 2021 to ₹4.88 in 2023, highlighting the company’s growing earnings power per share despite a slight decrease from 2022.
Asset and Liability Management:
Total assets have slightly increased, indicating cautious expansion and investment. The decrease in total liabilities and the substantial improvement in the debt-equity ratio, from 0.92 in 2021 to 0.39 in 2023, suggest a stronger balance sheet and reduced financial risk.
GPT Healthcare Ltd IPO Financial Information
| Particular | As of 31 March 2021 | As of 31 March 2022 | As of 31 March 2023 |
| Revenue (₹ in Million) | 2,427.53 | 3,374.15 | 3,610.37 |
| Equity (₹ in Million) | 1,339.01 | 1,581.82 | 1,653.62 |
| Expenses (₹ in Million) | 2,199.80 | 2,883.24 | 3,107.62 |
| Profit and Loss After Tax (₹ in Million) | 210.93 | 416.63 | 390.08 |
| RoNW (%) | 15.90 | 26.54 | 23.77 |
| NAV per Equity Share (₹) | 16.60 | 19.54 | 20.54 |
| Diluted EPS only (₹) | 2.64 | 5.21 | 4.88 |
| Total Assets (in millions) | 3,172.13 | 3,232.24 | 3,267.55 |
| Total Liabilities (in millions) | 1,833.12 | 1,650.42 | 1,613.93 |
| Debt Equity Ratio | 0.92 | 0.60 | 0.39 |
GPT Healthcare IPO Peer Comparison
GPT Healthcare Limited, with a RoNW of 23.77% and an EPS of ₹4.88, showcases strong profitability efficiency within its peer group, offering competitive returns despite lower total revenue compared to giants like Global Health and Krishna Institute of Medical Sciences.
| Company | Total Revenue (₹ in million) | Face Value per Equity Share (₹) | P/E | EPS(Basic) (₹) | EPS (Diluted) (₹) | RoNW (%) | NAV per Equity Share (Basic) (₹) |
| GPT Healthcare Limited | 3,610.37 | 10 | NA | 4.88 | 4.88 | 23.77 | 20.54 |
| Global Health Limited | 26,942.48 | 2 | 90.29 | 12.58 | 12.57 | 13.56 | 89.65 |
| Krishna Institute of Medical Sciences Limited | 21,976.78 | 10 | 49.51 | 42.03 | 49.51 | 20.35 | 206.47 |
| Jupiter LifeLine Hospitals Limited | 8,925.43 | 10 | 81.73 | 13.95 | 12.95 | 19.94 | 64.70 |
| Yatharth Hospital & Trauma Care Services Limited | 5,202.93 | 10 | 37.66 | 10.09 | 10.09 | 36.06 | 27.84 |
| Kovai Medical Center & Hospital Limited | 10,197.47 | 10 | 29.93 | 105.80 | 105.08 | 16.11 | 656.65 |
| Shalby Limited | 8,049.21 | 10 | 49.01 | 6.27 | 6.27 | 7.33 | 85.54 |
GPT Healthcare Limited IPO Objective
The main objective of GPT Healthcare is to repay or prepay certain portions of outstanding loans obtained from banks and financial institutions.
- Repayment or prepayment, in whole or in part, of all or a portion of certain outstanding borrowings availed by the company from banks and financial institutions: The company proposes to utilize an estimated amount of up to INR 30 crores from the Net Proceeds towards prepayment or scheduled repayment of all or a portion of term loans availed by the company, aiming to reduce debt burden, freeing internal funds for business growth and investment.
- General corporate purposes: The company plans to deploy the balance funds towards the general corporate goals, including strategic initiatives such as funding growth, acquisitions, brand building, capex, R&D, manufacturing, and meeting company expenses.
GPT Healthcare IPO Risks And Challenges
GPT Healthcare risk includes heavy reliance on revenue from specialized services in West Bengal and vulnerability to regional economic/political instability. Promoter’s involvement in default poses reputational risk, while fierce competition challenges pricing and talent retention.
- The company’s revenue heavily relies on three hospitals in West Bengal, contributing significantly due to specialized services. Any loss in revenue or adverse regional economic/political conditions could adversely affect business, finances, and operations.
- The involvement of Ishwari Prasad Tantia, a Promoter Group member, in wilful default and NSDL account freeze poses a reputational risk. Future adverse actions by regulatory authorities against any Promoter Group member could impact business operations.
- Operating in a competitive healthcare landscape, they face competition from various players offering diverse services. Competitors range from regional to pan-India chains and potential market entrants, posing challenges in pricing, talent retention, and market share retention.
GPT Healthcare Limited IPO – Industry & Market Potential
Long-term growth in the healthcare delivery market is anticipated at 9-11% CAGR, reaching Rs 9.2-9.3 trillion by fiscal 2028. Private players dominate due to government underinvestment, with their share expected to increase to ~70% by 2028.
Growing health insurance coverage in India (38% in FY22) creates opportunities for healthcare industry expansion. Expected to rise to 47-50% by FY27, driven by PMJAY and Covid-19, boosting demand and accessibility.
India’s medical tourism capitalizes on affordable surgeries, advanced facilities, and cultural affinity, particularly in Eastern India. Holistic wellness offerings like Ayurveda and Yoga differentiate India from competitors like Singapore and Thailand.
GPT Healthcare Ltd IPO – Type of Offer
GPT Healthcare consists of a fresh issue of shares, seeking INR 40 crores to augment the company’s capital needs. Additionally, the company proposes an offer for sale, intending to sell 2.60 crore existing shares.
- Fresh Issue: The company will issue new shares to raise capital, aiming to collect INR 40 crores. The company intends to utilize the proceeds from the fresh issue for loan repayment, prepayment, and general corporate funding purposes.
- Offer for sale: GPT Healthcare is offering to sell 2.60 crore existing shares.
GPT Healthcare IPO Offer Size
The offer size of GPT Healthcare is a fresh issue of shares worth INR 40 crores and an offer to sell 2.60 crore existing equity shares. The company seeks funds for loan repayment, prepayment, and general corporate funding purposes.
GPT Healthcare Ltd IPO Allotment Structure
GPT Healthcare allocation will be as follows: 50% for Qualified Institutional Buyers (QIB), 15% for Non-Institutional Investors (NII), and 35% for Retail Individual Investors (RII) in accordance with SEBI regulations.
● Qualified Institutional Buyers (QIB): As per SEBI regulations, 50% of the shares offered through the IPO will be reserved for Qualified Institutional Buyers. These include entities such as banks, mutual funds, and insurance companies.
● Non-Institutional Investors (NII): 15% of the shares will be reserved for Non-Institutional Investors. These typically include corporate bodies or individuals investing more than Rs.2 lakhs.
● Retail Individual Investors (RII): The remaining 35% of the shares will be allotted to Retail Individual Investors. These individual investors apply for shares with a total value of less than Rs.2 lakhs.
How to apply for a GPT Healthcare IPO?
To apply for the GPT Healthcare IPO through Alice Blue, you would typically follow these steps:
1. Open a Demat and Trading Account: If you don’t have one already, you would need to open a Demat and trading account with Alice Blue.
2. Check for IPO Details: Once your account is active, you can check for the GPT Healthcare IPO details in the IPO section of the Alice Blue platform.
3. Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
4. Submit the Application: Confirm all your details and submit your application.
You can apply for GPT Healthcare Limited’s IPO at Alice Blue in just a few clicks!
Check Allotment Status: Post the allotment process; you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How to check GPT Healthcare IPO Allotment Status on Alice Blue?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
1. Log in to your Alice Blue Account: You can do this through the Alice Blue website or their trading app.
2. Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
3. Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
4. Select the GPT Healthcare IPO: If you have applied for multiple IPOs, there might be a dropdown menu or lists where you can select the IPO you are interested in. Select the GPT Healthcare IPO.
5. Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, it’s recommended that you contact Alice Blue’s customer support for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the GPT Healthcare IPO:
Registrar’s Website: Visit the website of Link Intime India Private Limited, the registrar of the GPT Healthcare IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN and application number or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
NSE and BSE: You can also check the allotment status on the official websites of the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after the allotment process has been completed, a few days after the IPO window closes.
GPT Healthcare IPO Offer Registrar
The registrar for the GPT Healthcare IPO is Link Intime India Private Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
C 101, 247 Park,
L.B.S. Marg, Vikhroli (West),
Mumbai – 400083
Tel: +91 22 810 811 4949
E-mail: [email protected]
Website: www.linkintime.co.in
GPT Healthcare IPO FAQs
The allotment date of GPT Healthcare Ltd’s IPO is February 27, 2024.
The price band of the shares issued by the company is INR 177 to 186 per share.
GPT Healthcare IPO consists of a fresh issue of shares worth INR 40 crores and an offer to sell 2.60 crore existing equity shares. The company seeks funds for loan repayment, prepayment, and general corporate funding purposes.
The listing date of GPT Healthcare Ltd’s IPO is February 29, 2024.
